Archive for the ‘Treatment’ Category

What is Borrelia miyamotoi?

https://danielcameronmd.com/what-is-borrelia-miyamotoi/

WHAT IS BORRELIA MIYAMOTOI?

What is Borrelia miyamotoi

What is Borrelia miyamotoi? This tick-borne illness, transmitted by deer ticks, is believed to be underrecognized and a growing concern, as studies indicate a B. miyamotoi infection may be as common as anaplasmosis and babesiosis. Researchers randomly tested 250 individuals living in Manitoba, Canada and found that 10% were seropositive for B. miyamotoi. [1]

Borrelia miyamotoi (B. miyamotoi) was first reported in the United States in 2013 but has become increasingly more common.  The tick-borne illness can be transmitted by the same tick that carries Borrelia burgdorferi, the Lyme disease pathogen. In their article, Della-Giustina and colleagues² address the question, “What is Borrelia miyamotoi?” and concerns surrounding this growing threat.

Where is B. miyamotoi found?

Borrelia miyamotoi (B. miyamotoi) can be found in various ticks including the deer tick. It has been detected in ticks located in the northeastern and northern Midwestern United States, California, Europe, and Asia.

What stage of deer ticks transmit B. miyamotoi?

Borrelia miyamotoi can be transmitted from all stages of a tick including the larval stage. The larval tick can harbor and transmit B. miyamotoi by passing the pathogen from the parent to the offspring, a process called transovarial transmission.

How fast can B. miyamotoi be transmitted?

Quickly, according to the authors.  “B. miyamotoi can be transmitted 10% of the time within the first 24 hours of attachment, increasing steadily to reach 73% for a complete feeding.  Thus, transmission of B. miyamotoi is more rapid than transmission of B. burgdorferi.”²

Symptoms of B. miyamotoi

The symptoms that have been described include fever, malaise, headache, and myalgias.  Some cases present with an elevated liver test, low white count and abnormal liver tests that have been described in Anaplasmosis, another tick-borne illness.  Only 11% of patients presented with an erythema migrans rash, according to findings from a case series.

Making the diagnosis

It can be difficult to diagnose B. miyamotoi“No test specific to B. miyamotoi has been approved by the United States Food and Drug Administration as of October 2020,” the authors explain.

“The most specific test currently available in several public health and commercial laboratories is polymerase chain reaction (PCR) testing of blood or cerebrospinal fluid for the B. miyamotoi GlpQ enzyme.”

“Serologic testing of B. miyamotoi IgM and IgG antibodies is possible by a few commercial laboratories.” Unfortunately, it can be hard to interpret these tests, as they may cross-react to other spirochetes.  (The authors did not address the risk of cross reactions.)

“One test using this approach, the TBD serochip, is an array-based assay testing for 8 different tick-borne diseases, including B. miyamotoi. Developed in 2018, it is promising but has not yet become widely available.”

Treatment of B. miyamotoi 

There are no evidence-based trials to determine the best treatment for B. miyamotoi. Doxycycline has been suggested, as Lyme disease patients have improved with doxycycline.  “In vitro analysis has shown the susceptibility of B. miyamotoi to ceftriaxone, azithromycin, and doxycycline, with resistance to amoxicillin,” the authors explain.

Prophylactic treatment

Since B. miyamotoi can be transmitted rapidly, it may be prudent to consider prophylactic antibiotic treatment immediately, even if the tick has not been attached for 24 to 36 hours.

“Understanding this more rapid transmission of infection of B. miyamotoi may be a consideration in determining prophylactic treatment for tick bites with a shorter time of attachment in endemic areas for B. miyamotoi.”

References:
  1. Kadkhoda K, Dumouchel C, Brancato J, Gretchen A, Krause PJ. Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011-2014: a cross-sectional study. CMAJ Open. 2017;5(3):E690-E693.
  2. Della-Giustina D, Duke C, Goldflam K. Underrecognized Tickborne Illnesses: Borrelia Miyamotoi and Powassan Virus. Wilderness Environ Med. Jun 2021;32(2):240-246. doi:10.1016/j.wem.2021.01.005

____________________

**Comment**

I’m always extremely skeptical of ALL information given on transmission times as reality has shown a far different picture.  For more on this:  https://madisonarealymesupportgroup.com/2017/04/14/transmission-time-for-lymemsids-infection/   Important to note: minimum transmission time has never been determined and reality shows it can happen within a few hours.  Certain coinfections can happen within minutes.

Since Borrelia miyamotoi is not a reportable illness to the CDC, no one has any clue about prevalence but reports are coming in continually that it’s highly likely to be a much bigger problem than ‘authorities’ believe.

It was recently discovered that:

How to Protect Yourself From Ticks With Permethrin-Treated Clothing

https://danielcameronmd.com/permethrin-treated-clothing-causes-hot-foot-effect-ticks/

HOW TO PROTECT YOURSELF FROM TICKS WITH PERMETHRIN-TREATED CLOTHING

how-to-protect-yourself-from-ticks
Several studies have found that wearing permethrin-treated clothing can reduce the risk of tick bites. But very few studies have looked at the behavior of a tick when it comes in contact with permethrin-treated clothing. Does it climb onto the insecticide-soaked textile or avoid it entirely? Does permethrin actually kill ticks?

As more individuals begin to venture outside with warmer weather, there are often concerns over how to protect yourself from ticks. Researchers have examined not only the effectiveness of various repellents and protective clothing but also the behavior of individuals who are more likely to encounter ticks.

Researchers in Indiana looked at the protective measures used by recreational hikers in their state. Surprisingly, they found that only 9.5% of hikers used a tick repellent, even fewer (3.4%) wore protective clothing and only 2 individuals “indicated that they took a shower post-recreation and used that activity to search for tick bites.” [1]

Ultrasonic device

Meanwhile, investigators in Australia recently studied the efficacy of ultrasonic pest repellent devices against the Australian paralysis tick, Ixodes holocyclus. “As more than 80% of the ticks were not repelled within the confined area, this level of repellency is clearly insufficient to provide adequate protection from a potential tick bite,” they conclude. [2]

Permethrin-treated clothing

Several studies have looked at Permethrin-treated clothing in repelling ticks.  Sullivan et al. recruited state and county park employees from North Carolina to wear long-lasting Permethrin-impregnated (LLPI) clothing. The authors found that the clothing “retained Permethrin and bioactivity against ticks after three months of use in real-world conditions.” [3]

A study in Rhode Island aimed to provide insight as to how to protect yourself from ticks by examining Permethrin-treated footwear. The authors found that people wearing sneakers and socks treated with Permethrin were 73.6 times less likely to have a tick bite than those wearing untreated footwear. [4]

Meanwhile, another study explored the behavior of ticks when they encounter Permethrin-treated clothing. How do ticks react? Using a model that mimicked a pant leg or the arm of a long-sleeved shirt, scientists studied the behavior and fate of ticks when exposed to Permethrin-treated clothing. [5]

“Ticks approaching a textile impregnated with a strong non-contact spatial repellent (DEET) very rarely made physical contact with the treated textile,” according to Eisen and colleagues from the Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases at the Centers for Disease Control and Prevention. [4]

Tick behavior when exposed to Permethrin

However, Permethrin-treated textiles did not repel ticks without contact, as seen with DEET. In fact, the majority (88%) of nymphal ticks chose to move onto Permethrin-treated textile versus DEET-treated textile.

After coming in contact with the treated clothing, the ticks dislodged through a “hot-foot” effect.

“Ticks readily walked onto a Permethrin-treated textile…. but laboratory-reared ticks became visibly agitated, displaying a hot-foot effect, and escaped contact with the Permethrin-treated textile by tumbling downwards until they dislodged themselves completely from a textile-covered assay card.”

Unfortunately, field-collected ticks were hardier than laboratory-reared ticks and able to sustain longer contact with the treated textile. The authors postulated that field-collected ticks have been exposed to highly variable temperatures and humidity conditions which may result in slower absorption of Permethrin.

“However, by 1 and 24 hours post-exposure very few ticks displayed normal movement, thus presenting minimal risk to bite, regardless of whether they were reared in the laboratory or collected in the field.”

“Contact with Permethrin-treated textiles negatively impacts the vigor and behavior of nymphal ticks for >24 hours,” according to Eisen, “with outcomes ranging from complete lack of movement to impaired movement and unwillingness of ticks displaying normal movement to ascend onto a human finger.”

One day after exposure, a majority of ticks were completely motionless. The remaining ticks were able to recover.

“Ticks having recovered normal movement 1 day after exposure in our study most often ascended onto a finger when given the opportunity (and presumably also were capable of biting),” Eisen points out.

“In a real-life scenario, prolonged periods of time where ticks having fallen off a human host after contact with Permethrin-treated textile are unable to move will undoubtedly increase the risk of mortality due to desiccation or predation.”

“A scenario more difficult to address in a bioassay is when a tick makes initial contact with bare skin and subsequently approaches loose-fitting summer-weight Permethrin treated garments, such as shorts or a T-shirt,” states Eisen.

“In this case, the tick may walk underneath the treated textile and be contacted primarily from the dorsal side as the person moves and the clothing comes in and out of contact with the tick and the person’s skin.”

Permethrin is acutely toxic in high doses. The authors did not address the potential toxicity of Permethrin to humans. “Acute signs of toxicity to the central nervous system include incoordination, ataxia, hyperactivity, convulsions, and finally prostration, paralysis, and death,” according to a review by the National Research Council (US) Subcommittee to Review Permethrin Toxicity from Military Uniforms. [6]

Note: Users have been advised not to inhale Permethrin when treating clothes and not to apply Permethrin to the skin.

Article Updated: June 1, 2021

References:
  1. Anderson KR, Blekking J, Omodior O. Tick trails: the role of online recreational trail reviews in identifying risk factors and behavioral recommendations associated with tick encounters in Indiana. BMC Public Health. 2021;21(1):908. Published 2021 May 13. doi:10.1186/s12889-021-10940-4
  2. Panthawong A, Doggett SL, Chareonviriyaphap T. The Efficacy of Ultrasonic Pest Repellent Devices against the Australian Paralysis Tick, Ixodes holocyclus (Acari: Ixodidae). Insects. 2021;12(5):400. Published 2021 Apr 30. doi:10.3390/insects12050400
  3. Sullivan KM, Poffley A, Funkhouser S, et al. Bioabsorption and effectiveness of long-lasting permethrin-treated uniforms over three months among North Carolina outdoor workers. Parasit Vectors. 2019;12(1):52. Published 2019 Jan 23. doi:10.1186/s13071-019-3314-1
  4. Tick Encounter. https://www.tickencounter.org/prevention/permethrin
  5. Eisen L, Rose D, Prose R, et al. Bioassays to evaluate non-contact spatial repellency, contact irritancy, and acute toxicity of permethrin-treated clothing against nymphal Ixodes scapularis ticks. Ticks Tick Borne Dis. 2017.
  6. Health Effects of Permethrin-Impregnated Army Battle-Dress Uniforms (1994) by National Research Council. 1994. Washington, DC: The National Academies Press. https://doi.org/10.17226/9274. at https://www.nap.edu/catalog/9274/health-effects-of-permethrin-impregnated-army-battle-dress-uniforms. Last accessed 8/12/17.

____________________

It’s never simple, is it?

For more:

Gold Standard COVID Science in Practice: An Interdisciplinary Symposium

Gold Standard Covid Science in Practice

An Interdisciplinary Symposium

calling for immediate intervention

Presented by Doctors for Covid Ethics

Hosted by UK Column

July 29th and 30th

17.00pm – 22.00pm BST

23 Speakers over Two Days

Day 1

Session I: The False Pandemic

Session II: The Going Direct Reset

Tips From a Personal Trainer

Day 2

Session III: First Do No Harm

Session IV: The Hour of Justice

Closing Panel Session

Including

Prof. Sucharit Bhakdi MD

Dr. Reiner Fuellmich

Dr. Michael Yeadon

Professor Martin Haditsch

Catherine Austin Fitts

Dr. Thomas Binder

Associate Professor Michael Palmer

Professor Dennis Rancourt

Program Day 1

Thursday, 29 July

Session I with Prof. Martin Haditsch: The False Pandemic

17:00

Greetings and introduction

Opening Statement by Sucharit Bhakdi

17:10

“The SARS-CoV-2 Genome The evidence of its artificial origin”                 

Opening Plenary by Michael Palmer

17.30

The Laboratory Pandemic

With Ulrike Kämmerer

17.50

The False Pandemic

With Denis Rancourt

18.10

Planned Lockdown

A dialogue with Stefan Homburg and Sucharit Bhakdi

18.30

The Power of Masks

Conversation with Josef Thoma, Harald Walach and Martin Haditsch

18.50

“The Powerless Doctors”

Debate with Sam White, Thomas Binder, Charles Hoffe and Martin Haditsch

19.20

Panel Discussion

With all Session I participants lead by Martin Haditsch

Session II with Catherine Austin Fitts: The Going Direct Reset

19.50

The Going Direct Reset: The Pandemic is a Monetary Event

With John Titus

20.10

UK Central Bankers & the Economic Drivers

Discussion with Richard Werner, Catherine Austin Fitts and Taylor Hudak

20.30

How to Decentralize Control

Discussion with Richard Werner, Mark Skidmore, Patrick Wood and Catherine Austin Fitts

21.00

Panel Discussion

With all session II participants lead by Taylor Hudak

21.45

First Day Wrap Up and the program for the 2nd day

With Catherine Austin Fitts, Michael Palmer, Taylor Hudak

Program Day 2

Friday July 30

Session III with Michael Palmer: First Do No Harm

17.00

The Propaganda Matrix

The complicit role of the media

With Taylor Hudak, Patrick Henningsen, Michael Meyen and Catherine Austin Fitts

17.30

Vaccines: Emergency Authorization Abused                    

With Mike Yeadon

17.50

Pharmacokinetics and toxicity of mRNA vaccines                 

With Michael Palmer and Sucharit Bhakdi

18.10

The End of the Narrative                 

With Sucharit Bhakdi and Michael Palmer

18.40

Panel Discussion on Vaccinations                 

With Mike Yeadon, Sucharit Bhakdi, Michael Palmer and Taylor Hudak

19.00

Debate on Vaccine Passports

With Patrick Henningsen and Guests

Session IV : The Hour of Justice

19.30

Reviving the Nuremberg Codex                  

Conversation with Vera Sharav, Sucharit Bhakdi and Catherine Austin Fitts

19.50

The Hour of Justice                 

With Reiner Feullmich, Vera Sharav, Mary Holland, Patrick Henningsen and Guest

20.30

Final Panel Discussion

With Sucharit Bhakdi, Thomas Binder, Catherine Austin Fitts and Reiner Fuellmich, led by Michael Palmer

21.45

Closing Remarks by Sucharit Bhakdi

 

Go here for lifestream.

Stomach Pain Can Be a Symptom of Lyme Disease

https://danielcameronmd.com/neurologic-lyme-disease-presenting-as-abdominal-pain-in-71-year-old-patient/

STOMACH PAIN CAN BE A SYMPTOM OF LYME DISEASE

woman with stomach pain from lyme disease

“Although abdominal pain is generally not considered a sign of LD [Lyme disease], in this case report we describe a patient with unexplained severe abdominal pain that eventually turned out to be LD due to radiculopathy,” explains Stolk from the Haga Teaching Hospital in the Netherlands. [1]

The 71-year-old woman underwent an exhaustive evaluation to determine the cause of her abdominal pain. Tests included: CT scan of the chest and abdomen; whole body emission tomography-CT scan (PET-CT); colonoscopy; gastroscopy, and an MRI of the small intestines. Initially, doctors did not consider testing for Lyme disease as a cause of the patient’s stomach pain.

The woman was admitted to the hospital for pain management and other diagnostic workups.

READ MORE: Lyme disease manifests as abdominal pain in a young child

Approximately 8 weeks prior to her hospitalization, she experienced temporary lower back pain, myalgia, fever, burning sensations and tenderness on her head and upper legs and moderate stomach pain. Several weeks later, her abdominal pain worsened.

“Going over the history again, she emphasized that she had stayed in a high endemic area for ticks and had suffered a possible tick bite without any sign of erythema migrans,” writes Stolk and colleagues.

Lyme disease associated with stomach pain

Serologic testing and a spinal tap were consistent with Neurologic Lyme disease. The spinal tap revealed an elevated IgM antibody to Borrelia burgdorferi (Bb), a lymphocytic pleocytosis, markedly elevated IgM antibody index to Bb, and markedly elevated IgG antibody to Bb.

The authors point out that “Since the incidence of LD is rising it is important to realize that severe abdominal pain could be the first clinical manifestation of early neuroborreliosis.

After a 2-week course of intravenous ceftriaxone to treat Lyme disease, the woman’s symptoms, including stomach pain, resolved completely.

This case demonstrates the importance of re-examining a patient’s history when symptoms cannot be explained, the authors point out.

“Instead of doing extensive diagnostic tests, it is important to scrutinize the patient’s medical history in the presence of unexplained clinical signs.”

The authors note: Abdominal pain in the presence of facial paralysis has been described in Europe as Bannwarth Syndrome.

Editor’s note: I often see Lyme disease patients in my practice who present with stomach pain severe enough to warrant extensive diagnostic testing before Lyme disease is suspected.

UPDATED: May 28, 2021

Research Consortium Aims to Develop New Drug For Bartonellosis

https://www.lymedisease.org/research-consortium-bartonellosis/

Research consortium aims to develop new drug for bartonellosis

July 15, 2021

Key infectious disease researchers at Tulane University, Duke University and North Carolina State University will collaborate on an initiative to develop a treatment for bartonelloses, a spectrum of vector-borne diseases that can cause debilitating symptoms.

The three-year, $4.8 million initiative funded by The Steven and Alexandra Cohen Foundation, will establish the Bartonella Research Consortium to develop a novel treatment for bartonelloses.

Bartonella are zoonotic, stealth bacterial pathogens that were not known to infect animals or humans prior to the HIV epidemic when immunocompromised patients began showing symptoms of bartonelloses.

Bartonelloses are often self-limiting diseases that can be cleared by the immune systems of healthy individuals. In immunocompromised individuals or as co-infections, they can cause severe neuropsychiatric, cardiovascular, and rheumatological symptoms. Cats and fleas often harbor the pathogen, which increases the likelihood of transmission to humans.

The principal investigators of the consortium support a collaborative approach to the study of complex, poorly understood infectious diseases. By working together to prevent and treat Bartonella infections, they will provide patient-relevant solutions that improve both animal and human health. Targeted antimicrobial strategies to eliminate long-standing Bartonella infections will dramatically improve patient outcomes.

Similarities between Bartonella and Lyme infections

Bartonella symptoms overlap with those of other vector borne organisms such as Borrelia burgdorferi, the bacteria that causes Lyme disease. In some instances, patients have been infected with both Bartonella and Borrelia burgdorferi infections, which can cause an exacerbation of symptoms

As often seen in Lyme disease patients, a subset of people with bartonelloses develop chronic symptoms despite prior antibiotic therapy. Treatment failures have been documented with both infections, thus the need for drugs that specifically target and eliminate these bacteria.

Associate Professor Monica Embers, a microbiologist and immunologist at the Tulane National Primate Research Center, focuses on the persistence of tick-borne infectious disease despite antibiotic therapy and will bring her expertise to the consortium.

“There are a lot of similarities between Bartonella and Borrelia infections, both of which are notoriously difficult to detect and treat. Developing targeted treatments has the potential to alleviate a lot of suffering, both in the human and pet populations,” said Embers.

There are over 40 known Bartonella species or subspecies and at least 17 have been associated with a spectrum of disease symptoms. Although Bartonella remain neglected in human and veterinary medicine, more recent evidence supports an important role for these bacteria in a variety of diseases.

Funding for this research initiative combines the strengths of research laboratories located at Duke University, North Carolina State University and Tulane University.

Principal investigators include Drs. Edward B. Breitschwerdt, Monica E. Embers, Timothy A Haystead and Ricardo G. Maggi. During the next three and a half years, these established investigators and their highly skilled research teams will develop a novel drug for the treatment of bartonelloses.

SOURCE OF PRESS RELEASE: Tulane University

__________________

For more: